Literature DB >> 28333830

Minimal variation in anti-A and -B titers among healthy volunteers over time: Implications for the use of out-of-group blood components.

Ulrik Sprogøe1, Mark H Yazer, Mads Hvidkjær Rasmussen, Berit Antonsen, Claus Bistrup, Kristian Assing.   

Abstract

BACKGROUND: Using potentially out-of-group blood components, like low titer A plasma and O whole blood, in the resuscitation of trauma patients is becoming increasingly popular. However, very little is known whether the donors' anti-A and/or anti-B titers change over time and whether repeated titer measurements on the same donor are required to ensure that each donation produces a low titer product.
METHODS: The anti-A and/or anti-B titers were measured on 56 healthy adult volunteers (47 blood donors; nine blood center personnel) every 3 months for 12 consecutive months using an automated solid phase analyzer. The results were expressed as log2 titer steps (e.g., titer 32 = 5 titer steps).
RESULTS: Minor variations in the average anti-A and/or anti-B titers were seen over time; the maximum individual SD in each group was 1.50 (IgG anti-A) or 1.00 (IgM anti-A, IgM, and IgG anti-B). When the SDs for the four titer measurements from all 56 volunteers were combined as appropriate, the highest overall combined SD was 0.47 titer steps for IgG anti-A. This value corresponds to a 95% confidence interval for intraindividual variation in this antibody's titer over 12 months of 0.96 titer steps. Thus, based on one measurement, an IgG anti-A with a titer step of, for example, 6 would be expected to be in the range of titer step 5 to titer step 7 over the course of 1 year with 95% probability.
CONCLUSION: The titers of anti-A and/or anti-B among healthy adults are stable over at least 1 year. This suggests that repeated titer measurements within a year on the same donor are not necessary if donations are made at 3 months or longer intervals. LEVEL OF EVIDENCE: Diagnostic study, level V.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333830     DOI: 10.1097/TA.0000000000001432

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  3 in total

1.  Increased but stable isoagglutinin titers in hemodialysis patients.

Authors:  Kristian Assing; Ulrik Sprogoe; Christian Nielsen; Mads Rasmussen; Mark Yazer; Claus Bistrup
Journal:  J Nephrol       Date:  2018-07-31       Impact factor: 3.902

2.  Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma.

Authors:  Gayathiri Kc; Mohandoss Murugesan; Sangeetha K Nayanar; Riyas Malodan; Maya Padmanaban
Journal:  Hematol Transfus Cell Ther       Date:  2020-06-15

3.  Lower Levels of ABO Anti-A and Anti-B of IgM, IgG and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents.

Authors:  Eva M Matzhold; Günther F Körmöczi; Chiara Banfi; Marlies Schönbacher; Camilla Drexler-Helmberg; Ivo Steinmetz; Andrea Berghold; Peter Schlenke; Gabriel E Wagner; Anja Stoisser; Barbara Kleinhappl; Wolfgang R Mayr; Thomas Wagner
Journal:  J Clin Med       Date:  2022-08-02       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.